Fulcrum Therapeutics Stock Predictions

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa

Buy

FULC
Fulcrum Therapeutics

Last Price:

$7.17

Seasonality Move:

57.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Notable investors are buying this "unlisted" stock

Fulcrum Therapeutics Stock Forecast

Over the next 52 weeks, Fulcrum Therapeutics has on average historically fallen by 2.5% based on the past 5 years of stock performance.
Fulcrum Therapeutics has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Is Fulcrum Therapeutics Stock Undervalued?

The current Fulcrum Therapeutics [FULC] share price is $7.17. The Score for FULC is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
FULC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Fulcrum Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Fulcrum Therapeutics has on average historically fallen by 2.5% based on the past 5 years of stock performance.

Fulcrum Therapeutics Stock Rating

Buy

Fulcrum Therapeutics (FULC) is a Buy

Is Fulcrum Therapeutics overpriced?

Fulcrum Therapeutics has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Fulcrum Therapeutics Stock Price History

Is FULC stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FULC is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

fulcrumtx.com

52-Week Data

52-Week High:

10.13

52-Week Low:

2.32

Prediction Charts

Market Cap:

387M

Price in USD:

7.17

Volume:

Beta:

2.43

Technical Analysis

SMA50:

5.54

SMA100:

4.44

SMA200:

4.32

52-Wk Change:

7.34%

Stock Predictions

Is Fulcrum Therapeutics stock public?

Yes, Fulcrum Therapeutics is a publicly traded company.
What is the Fulcrum Therapeutics stock quote today?

The Fulcrum Therapeutics stock price is 7.17 USD today.
How to buy Fulcrum Therapeutics stock online?

You can buy Fulcrum Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jun-3	6.96	7.04	7.17	6.82
Jun-4	7.03	7.03	7.10	6.83
Jun-5	7.03	7.11	7.40	6.89
Jun-6	7.23	7.25	7.40	7.10
Jun-9	7.30	7.12	7.39	6.99
Jun-10	7.12	6.90	7.23	6.89
Jun-11	6.93	6.83	7.17	6.68
Jun-12	6.74	6.78	6.92	6.66
Jun-13	6.60	6.85	6.93	6.60
Jun-16	6.83	6.80	6.97	6.61
Jun-17	6.78	6.43	6.87	6.33
Jun-18	6.42	6.36	6.74	6.33
Jun-20	6.37	7.00	7.21	6.28
Jun-23	6.98	7.17	7.45	6.83

Fulcrum Therapeutics Earnings

Fulcrum Therapeutics Earnings Report: Per Share Fulcrum Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Fulcrum Therapeutics Forecast Revenue Growth

Fulcrum Therapeutics Stock Analysis: Historical quarterly revenues per share for Fulcrum Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.30 per share, an increase next quarter of $0.43 per share, a decrease this year of $1.02 per share, and a decrease next year of $0.01 per share.

* Fulcrum Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.